Zyban, originally intended for use as an anti-depressant, was found to be useful in helping people stop smoking, regardless of whether depressed or not.
The canadian Medical Association Journal that a widely prescribed anti-depressant and anti-smoking drug has potentially deadly side effects.
Zyban, also marketed as Wellbutrin, is manufactured by the Drug Company GlaxoSmithKline. It has been prescribed to about 2 million people since 1998, and there have been problems associated with the drug, including 19 deaths in Canada.
Last July, GlaxoSmithKline issued a warning to the doctors about potentially serious side effects associated with the drugs, including seizures and convulsions. Health Canada re-issued the warning in September. People on the medication ZYBAN need to have their risk profile assessed before it’s prescribed and they need to be monitored.